Clinical Trial Update: Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study [Phase 4]

View source ↗

Summary

Phase 4 CAP Study evaluates apixaban for treatment of venous thromboembolism in cancer patients; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Neoplasms, Venous Thrombosis | Phase 4 | Status: COMPLETED